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Treatment of chronic hyponatremia in rats by intravenous saline:
Comparison of rate versus magnitude of correclion. The role of the rate
of correction in the development of demyelinating brain lesions after
correction of chronic severe hyponatremia is controversial. It has been
recently suggested in rats treated by intravenous (i.v.) hypertonic saline
(NaC1) that both the rate and the absolute change in serum sodium
represent critical risk factors. However, we previously demonstrated in
rats treated by intraperitoneal (i.p.) injections of NaCI that below a
threshold of serum sodium rise of 20 mEq/liter/24 hr, only 5% of the
brain lesions were recorded, even in rats submitted to a rapid (1 hr)
serum sodium increment following the i.p. injection. Working below
this threshold (serum sodium rise < 20 mEq/liter/24 hr) in the present
work, allowed us to independently determine the role of the rate in the
outcome of the correction. This was done by submitting the rats to a
rapid (1 hr) intravenous infusion of NaCI. As a difference between the
i.p. and iv, route in the degree of volume expansion produced by the
NaCI administration could also play a role in the pathogenesis of the
brain lesions, rats treated with rapid i.v. infusion of NaCI (associated
with volume expansion) were compared to a group of rats treated with
water restriction (associated to volume contraction) to evaluate the role
of volemia on the incidence of neurological damage. Hyponatremia was
induced over three days with d-glucose in water and vasopressin, The
group 1 was corrected by intravenous (i.v.) infusion of hypertonic saline
over one hour. Rats achieved a serum sodium correction of 12 0.5
mEq/liter (8 to 17 mEq/liter) at the end of the infusion and of 13.5 0.6
mEqlliter (8 to 19 mEq/liter) after the first 24 hours. Group 2 was
submitted to spontaneous correction with water restriction over 48
hours. The maximum daily increment in serum sodium observed during
this period in this group was 14.8 0.5 mEq/liter (9 to 19 mEq/liter). No
difference could be observed in the incidence of brain lesions between
both groups. Only one rat (1 of 25) was damaged in group 1 and two rats
(2 of 24) in group 2, an incidence similar to our previous results. We
conclude that: (1) A rapid (1 hr) and large (12 mEq/liter, range 8 to 17
mEq/liter in 1 hr) rise in serum sodium after NaCl administration is well
tolerated provided that the limit of daily absolute change in serum
sodium (20 mEq/liter/24 hr) is not exceeded. In these conditions, the
rate of the correction is not important; (2) In the same conditions, a
correction associated with an acute (1 hr) volume expansion (NaC1 i.v.)
is not more toxic for the brain than water restriction (volume contrac-
lion) alone.
The mechanisms responsible for the development of the brain
demyelinating lesions which can develop after the correction of
severe (<115 mEq/liter) chronic (>48 hr) hyponatremia remain
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highly controversial [1—51. Brain demyelinating lesions are
probably the result of the osmotic stress induced by the serum
sodium rise which can lead to excessive brain dehydration [61.
Supporting this hypothesis, recent experiments suggest that the
initial damage could be a mechanical separation of the axon
from its surrounding myelin sheath, as observed shortly after an
"excessive" osmotic gradient [7, 81. Factors like hypokalemia
[9], nutritional status or hypoxic insult [101 could also contrib-
ute to the pathogenesis of brain damage, independently of the
correction methods. However, disagreement particularly con-
cerns the respective role of the magnitude and of the rate of
serum sodium correction in the pathogenesis of brain demyeli-
nation [1, 11, 121. Yet, recent animal experiments have pro-
vided important data by demonstrating the critical role played
by the absolute change in serum sodium in the development of
brain damage [13—15]. Likewise, we recently reported in rats
corrected over 48 hours that the first brain lesions appear, for
95% of the injured rats, when the daily absolute change in
serum sodium reached 20 mEq/liter/24 hr. Below this limit, the
incidence and severity of brain lesions were very low, even in
the group corrected with intraperitoneal (i.p.) bolus injections
of hypertonic saline (NaC1) and despite the fact that this method
leads to a rapid (1 hr) and large (mean value 19 mEq/liter)
increment in serum sodium [15]. We concluded from these
observations that the critical factor for the brain is the threshold
of absolute change in serum sodium as proposed in previous
studies [12—141 (this limit is, however, not entirely independent
of the concept of rate of correction as it is defined for a 24 hr
period of time). Our results also suggested that below this limit
of 20 mEq/liter/24 hr the rate of correction is probably not
important. On the contrary, Verbalis, Martinez and Dutarosky
recently showed in data pooled from chronic hyponatremic rats
corrected by either slow intravenous (i.v.) infusion of NaC1 or
water restriction, that the incidence of brain lesions was 64%
when the maximal correction rate exceeded 4 mEq/liter/hr at a
given time or if the daily rise in serum sodium exceeded 25
mEq/liter/24 hr. They concluded that brain damage is a function
of both rate and magnitude of correction [161. In an attempt to
elucidate this apparent discrepancy about the exact role of the
correction rate, two different approaches were considered.
Firstly, the previous determination of the toxic threshold for
the brain of daily serum sodium increment permits, by working
below this limit, evaluation of the rate of correction as an
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independent risk factor in the development of demyelinating
lesions,
The second issue concerns the susceptibility of the brain to
the degree of volume expansion induced by the correction
method [16]. Intraperitoneal injection of NaC1 is the method
currently used to correct hyponatremia in rats [6, 13—15, 17—19].
However, the i.p. injections are followed, during the early
hours, by a shift of water into the peritoneal cavity and a fall in
arterial pressure [18, 19], so that the degree of volume expan-
sion could be initially less important in the i.p. model than with
the intravenous NaCl route.
If there is no doubt that fluid restriction (volume contraction)
alone can produce demyelination [12, 13, 20], it is conceivable
that an acute volume expansion produces a more deleterious
effect on the brain, explaining a higher susceptibility to the
correction rate in rats treated with the i.v. model of NaC1
administration [16].
Methods
Animals
The study was performed on male Wistar rats (N 59)
weighing 400 to 550 g (aged 3 to 5 months).
Animals were housed in individual cages and were allowed 10
days to adapt before starting the study, with free access to
pelleted rat chow and tap water. Room temperature was con-
trolled (20°C) with lights on from 7 a.m. to 7 p.m.
Induction of severe chronic hyponatremia (days 1 to 3)
Profound (<115 mEq/liter) chronic hyponatremia was in-
duced as previously described [13, 14]. Rats received subcuta-
neous injections of 0.5 U of vasopressin tannate in oil (Parke-
Davis) per 100 g body wt and intraperitoneal injections of 2.5%
(140 mM) d-glucose in water equivalent to 5% initial body wt
twice daily (09 a.m. and 17 p.m.) on day 1, to 3% initial body wt
once daily (12 hours) on day 2, and 3% initial body wt twice
daily on day 3. Animals were kept under light ethyl ether
anesthesia at time of injection. Animals had no access to food or
water during this phase of the experiment [15].
Correction of hyponatremia (days 4 and 5)
Two separated groups of rats were studied. The correction
was performed in a 48 hour period of time, consisting of the
administration of intravenous NaCI over one hour and then
water restriction in one group, and of water restriction alone in
the other. In our previous work [151 where the rats were
corrected over 48 hours, we observed that the animals
achieved, without predictive clues, a large increment in serum
sodium (MSNa) one of the two days, and a lower rise in serum
sodium the other day. However, no difference could be ob-
served in the incidence or severity of brain lesions whether the
large increase in serum sodium occurred during the first or the
second correction day. In both groups, rats had free access to
the laboratory diet and tap water from day 6 to day 8 (time of
death) [15].
Group 1 (N — 25)
In this group, rats had indwelling femoral venous polyethyl-
ene catheters (PE-lO, Clay-Adams, Becton Dickinson, Parsip-
pany, New Jersey, USA) inserted on day 4, just before the
NaCL administration under pentobarbital sodium anesthesia
(Nembutal, Abbott, 25 mg/kg i.p.). This enabled continuous
rapid infusion of hypertonic saline at a controlled rate via
syringe pumps (model 11, Harvard Apparatus, South Natick,
Massachusetts, USA). Hypertonic saline (1 M NaCl) was in-
fused at a rate of 1 ml/100 g body wt/hr during one hour to
produce a rapid and significant increment in serum sodium
concentration, but which did not exceed the threshold of 20
mEq/liter.
After 60 minutes, the infusion was stopped and the femoral
catheter was removed. Rats were then maintained in their cages
from day 4 to day 8 with no access to food and water during the
two days of the correction period (day 4 and 5). Subcutaneous
injections of vasopressin were continued (0.5 U/100 g once a
day) from day 4 to day 8 to avoid excessive correction (change
in serum sodium maintained <20 mEq/liter/day) during this
period. Blood samples (0.25 ml) were collected via tail transec-
tion while the rats were under light ether anesthesia. Blood was
drawn: on day 4 to measure serum sodium at time of hypona-
tremia, just before the NaC1 infusion; at the end (1 hr) of the
perfusion and on day 5 (24 hr after treatment); day 6 (48 hr after
treatment); day 7 (72 hr after treatment); and on day 8 (at time
of death). Serum sodium was measured after centrifugation
(3000 X g for 10 mm) via ion-specific electrodes (Microlyte,
Kone, Espoo, Finland).
In 10 out of the 25 rats, plasma proteins (10 pi) (quantitative
colorimetric determination, Vitalab 21, Vital Scientific Indus-
tries, Dieren, The Netherlands) and microhematocrit were
measured on day 4, just before correction and at the end (1 hr)
of the i.v. NaC1 administration. Microhematocrit was measured
in duplicate in each sample collected at the same time as protein
measurements were done. Ten additional animals not included
in the initial group of 25 rats were used as controls in normal
conditions for serum sodium, plasma proteins concentration
and microhematocrjt determinations.
Group 2 (N = 24)
In this group, rats were submitted to spontaneous correction
under water restriction, with no access to water and food during
the correction period (days 4 and 5). Injections of vasopressin
were stopped on day 4. Serum sodium was measured every 24
hours from day 4 to day 8 (at time of the death).
Histological examination of the brains
During day 4 to day 8, rats were weighed daily and closely
observed and any neurological dysfunction was recorded. On
day 8, rats were decapitated and the brain removed and
immediately placed in 10% buffered formaldehyde for ten days.
Afterwards, brains were sectioned coronally at six levels, and
processed for light microscopy as previously described [15, 21].
Briefly, sections were stained with hematoxylin-eosin for eval-
uation of neuronal density and Luxol fast blue for evaluation of
myelin integrity. The sections were independently examined by
two neuropathologists (O.P.; A.ST.) without knowledge of the
treatment group of the animals.
Statistical analysis
All values are expressed as means SE. To determine
statistical difference of various parameters between different
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Table 1. Comparison of SNa, SNa values and brain lesions between rats treated with rapid (1 hr) intravenous infusion of hypertonic saline
and rats corrected by water restriction
SNa SNa
SNa at the end 24 hr after SN
at time of of NaCI NaC1 i.v. at time No. of rats
hyponatremia i.v. infusion infusion of death with brain Location of brain
(day 4) (1 hr) (day 5) MZSNa (day 8) lesions lesions
Group 1 (N = 25) 102 1.2 12 0.5 13.5 0.6 — 137 0.8 1/25 Thalamus symmetrical
Range (90—113) (8—17) (8—19) (126—144) (N = 1)
NaCI i.v.
Group 2 (N = 24) 104 1.1 — — 14.8 0.5 137 0.5 2/24 Thalamus symmetrical
Range (91—114) (9—19) (130—143) (N = 2)
Water restriction
Data are means SE. Abbreviations are: SNa, serum sodium; ASNa, absolute change in SNa; MLSNa, maximum daily hSNa observed in group
2 during one of the two days of the correction period (day 4 or 5).
The other days, the mean ASNa are 3.4 0.6 mEq/liter (day 5) and 12 0.9 mEq/liter (day 6) for group 1, and 9 0.6 mEq/liter (day 4 or 5)
and 5 1 mEq/liter (day 6) for group 2.
groups, conventional t-tests and paired t-test for difference
within groups at different times were used.
Results
In the present study, including a total of 59 rats, the serum
sodium values at time of hyponatremia (day 4) were similar in
both group 1 and 2 (Table 1) and all rats presented severe (<115
mEq/liter) hyponatremia. We have observed a mortality rate of
10% during the induction of hyponatremia which is lower than
in our previous experiments [15, 21].
This can be explained by the lower total amount of fluid
infused in the present model. It must be noted that in the
different animal studies, the mortality rate ranged from 63% to
20% [14, 22, 231.
For each rat in both groups, the daily change in serum sodium
never exceeded 19 mEqfliter/24 hr from day 4 to day 8.
Group 1: Rapid correction with intravenous NaCI
The purpose of this protocol was to evaluate the tolerance of
a rapid (1 hr) correction of the serum sodium but with an
absolute change remaining below the threshold of 20 mEq/
liter/24 hr. This has been achieved in 25 rats with a method of
correction (intravenous NaC1) which produces a concomitant
volume expansion.
At the time of hyponatremia, the rats stayed motionless and
drowsy in their cages with relatively few responses to stimula-
tion. No convulsions or respiratory arrests were recorded. The
one hour infusion of NaCl produced a mean increment in serum
sodium of 12 0.5 mEq/liter (range 8 to 17 mEq/liter), (+ 11%)
which increased the serum sodium to a mean level of 114 1.1
mEq/liter (range 107 to 125). Immediately after awaking from
their anesthesia, the rats became alert with normal neurological
function. Natremia did not increase significantly during the
subsequent hours and the mean change in the first 24 hours (day
4) was 13.5 0.6 mEq!liter (range 8 to 19 mEqlliter). As for the
first day of correction, all the rats achieved during the subse-
quent days a daily rise in serum sodium below the limit of 20
mEq/liter/24 hr with mean daily increment of 3.4 1.0 mEq/
liter during the second day (day 5, range 0 to 12) and 12 0.9
mEq/liter (range 1 to 18) on day 6. The larger increment on day
6 is explained by the osmotic diuresis arising when the animals
again have free access to food and water [16]. At day 8, all the
rats had survived and had corrected their natremia (>135
mEq/liter), except one rat (final natremia 126 mEq/liter).
As shown in Table 1, the maximum daily absolute change in
serum sodium during the correction period was similar in group
1(13.5 0.6 mEq/liter in the first 24 hr) and in group 2 (MSNa,
14.8 0.5 mEq/liter, mean value of the highest increment in
serum sodium achieved by the rats during either day 4 or 5).
Brain histology was normal in 24 out of the 25 rats included in
this group. None of the 24 undamaged rats presented symp-
toms. Only one rat developed brain lesions (1 of 25; 4%). This
rat was free of symptoms and presented limited (focal) symmet-
rical demyelinative lesions in the thalamus. Histopathological
analysis demonstrated cellular necrosis with gliovascular pro-
liferation, fat loaded cells and demyelination. Its change in
serum sodium was 13 mEq/liter after the first 24 hours, 4
mEq/liter on day 5 and 18 mEq/liter on day 6.
The acute volume expansion induced by the intravenous
infusion of hypertonic saline is illustrated in ten rats by the
changes at the end of the NaCl administration, of the microhe-
matocrit (mean value in hyponatremia 51 2%, after 1 hr NaCl:
45 1; —11%, P < 0.001) and the plasma protein concentra-
tions (mean value in hyponatremia 5.6 0.5 gldl, after 1 hr
NaC1: 4.6 0.2; —'17%; P < 0.001) for a mean increment in
serum sodium of 12 0.7 mEqlliter (+11%; mean value in
hyponatremia 103 2 mEq/liter; after 1 hr NaCl 115 1.6
mEq/liter; P < 0.001).
Control values for serum sodium, hematocrit and plasma
proteins were respectively: 139 0.4 mEqlliter, 48 1% and
6.8 0.2 g/dl.
Group 2: Water restriction
The purpose of this protocol was to evaluate the tolerance of
a correction by a method producing a volume contraction
(water restriction) and to compare it to the group 1 submitted to
an acute volume expansion. During the two days of the correc-
tion period (days 4 and 5) nine rats achieved their largest
absolute change (MZSNa) in the first day (day 4, mean value 16
0.6 mEq/liter) and 15 rats in the second day (day 5 mean value
14 0.7 mEq/liter). When the MASNa of each rat achieved
during day 4 or day 5 are pooled, the mean value of MSNa is
14.8 0.5 mEq/liter (range 9 to 19). This is not different from
the mean largest daily increment in serum sodium observed in
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group 1 (13.5 0.6 mEq/liter Table 1). Brain analysis was
normal in 22 out of the 24 rats included in their group and all of
them were free of neurological symptoms. Two rats had brain
injuries (2 of 24, 8%). The first one achieved a MLSNa of 14
mEq/liter (achieved on day 5) and was free of symptoms.
Diffuse demyelinative lesions were observed symmetrically in
the thalamus.
The other rat was symptomatic with paralysis of the limbs. Its
MSNa was 16 mEq/liter (achieved on day 4) and also presented
diffuse symmetrical demyelinative lesions in the thalamus. In
both rats, the lesions were characterized by gliovascular prolif-
eration, fat loaded cells, cellular necrosis and demyelination.
As shown in Table 1, no difference could be observed in the
incidence of brain lesions between rats rapidly corrected via a
volume expansion model (1 of 25, 4%) and rats corrected by the
volume contraction model (2 of 24, 8%). Provided that the
threshold of daily change in serum sodium of 20 mEqlliter
defined previously [15] was not exceeded, neither the methods
tested here nor the rate of correction were determinant risk
factors for subsequent development of brain damage.
Discussion
This work addresses two major questions in view of the
optimal management of severe chronic hyponatremia. The first
and widely debated one, concerns the rate of correction: is the
rapidity of the serum sodium increment a critical factor which
must be closely monitored during the therapy of hyponatremia?
It is generally accepted that high rates of increase in serum
sodium are well tolerated in acute hyponatremia [12, 23, 24]
with, however, occasional reports of myelinolysis [19, 25, 26].
Demyelination is more likely to develop after chronic (>48
hr) hyponatremia which renders the brain more susceptible to
excessive dehydration during correction [61. The previous
animal experiments, with the exception of the recent work of
Verbalis et a! [16], did not provide appropriate data allowing us
to evaluate the exact role of the correction rate in the develop-
ment of brain damage. Indeed, studies demonstrating demyeli-
nation are characterized by both high rates and large magnitude
of serum sodium increment [13, 14, 17].
The present study confirms [11, 14, 15] the hypothesis first
advanced by Ayus et al [lii, suggesting the lack of influence of
the rate on the outcome of the correction, the determinant risk
factor being the absolute change in serum sodium during the
first 24 hours. Indeed, by using daily changes in serum sodium
ranging below the critical threshold to correct chronic hypona-
tremic rats, this model permitted independent evaluation of the
effect of rapid (1 hr) and large (8 to 17 mEq/Iiter in 1 hr)
increments in serum sodium obtained by i.v. infusion of NaC1.
At the end of the infusion time, the neurological status frankly
improved and symptoms related to hyponatremia disappeared.
Despite this overaggressive approach, only one rat (1 of 25, 4%)
developed mild demyelinative lesions, an incidence comparable
with our previous results in rats corrected either slowly (NaC1
i.p. in divided doses, urea) or rapidly (NaCl i.p. in boluses)
[15]. Although our results demonstrate that for a magnitude of
correction remaining <20 mEq/liter/24 hr the rate to achieve
this goal does not influence the outcome, these findings do not
conflict with the conclusions of Verbalis et a! [16]. In their
study, demyelinative changes were observed in the brain of
64% of rats whose maximum rate of serum sodium rise ex-
ceeded 4 mEq/liter/hr at a given time, or whose total increment
in serum sodium exceeded 25 mEq/liter during the first 24
hours. Thus, our rats safely achieved correction rates (12
mEq/liter in 1 hr, range 8 to 17 mEq/liter) largely above the
"toxic" limits defined by Verbalis et al. This apparent discrep-
ancy is explained by the fact that their series included few rats
submitted to a daily change in serum sodium <20 mEq/liter with
concomittant high maximal correction rates (>4 mEq/liter/hr);
only three rats presented with these characteristics (maximal
correction rates of 5.5, 5.8 and 7 mEq/liter/hr), two of them
being injured [161. Their conclusions are drawn from data
obtained in the rats submitted to daily change in serum sodium
>20 mEq/liter/24 hr, and over this threshold, the rate of
correction probably represents a significant risk factor.
We clearly demonstrated here for the first time that a rapid
and large intravenous infusion of hypertonic saline is safe
provided that the limit of daily increment in serum sodium is not
exceeded. Placed into a clinical perspective, even if a rapid
correction is not always necessary, our results can help the
physician to feel more comfortable with the therapeutic ap-
proach of the severe hyponatremic patients, knowing that,
during the initial phase of the treatment, the serum sodium
could be corrected rapidly without fear of permanent neurologic
sequelae. This is more critical especially because some patients
with severe symptomatic hyponatremia (precise duration of the
electrolyte disturbance is frequently unknown) need prompt
correction to avoid the possible dramatic consequences of
untreated severe hyponatremia [1, 3, 11, 12, 14, 27]. In this
situation the osmotic gradient produced by a rise in serum
sodium lower than 4 mEq/liter, as proposed as a risk factor by
Verbalis et a!, perhaps is insufficient to significantly reduce
brain edema. Moreover, in some cases, a spontaneous return of
a normal diluting ability could induce an unpredictable rapid
rise in serum sodium. One could also expect that, if brain
damage was so strongly correlated with hourly changes in
serum sodium (>4 mEq/liter/hr), myelinolysis should be more
frequently encountered in the clinical setting [11].
We have employed in this work the currently used three-day
model for chronic hyponatremia, which is of relatively short
duration [6, 13, 14, 17—19, 23, 281 compared to the model used
in the work of Verbalis et al where hyponatremia was main-
tained during 19 days [16]. However, if the chronicity of
hyponatremia logically could enhance the brain susceptibility to
the subsequent correction [6, 19, 28], after three days of
hyponatremia the brain adaptative mechanisms to the hypoos-
molar state have almost fully taken place [29, 30]. Therefore
this would probably not explain the good tolerance to the
aggressive regimen undergone by the rats in our study. By
another way, we used in the present work AVP rather than
DDAVP [16] to induce the hyponatremia. AVP use is in fact
more physiological since vasopressin, unlike DDAVP, has
specific effects on the V1 receptors in the brain and could
influence brain ion and volume homeostasis. From data ob-
tained in Brattelboro rats [31] one could logically hypothesize
that, in the presence of AVP, the brain will better support the
osmotic stress related to the correction of the hyponatremia
than the brain of DDAVP treated rats could do. Another risk
factor which must be also considered during hyponatremia is
related to the hypoxic-anoxic episodes which can occur as a
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consequence of seizures and respiratory arrests. This compli-
cation which can lead to permanent brain damage is usually
associated with acute hyponatremic state [27]. Likewise, it has
been recently shown in rats that hypoxia may render the brain
more susceptible to hypoxic injury and death [101. If we have
not observed episodes of convulsions in the present study,
hypoxia cannot be completely excluded as a cause of brain
damage in this chronic model [14]. Yet, several series of rats
submitted to severe protracted hyponatremia failed to demon-
strate any histological brain changes [13, 16, l8J.
The second question considered in the present work was the
influence of the correction methods and the associated degree
of volume expansion on the outcome of hyponatremia. In
several previous experimental works, different methods were
used to correct the hyponatremic state (mainly i.p. NaC1, water
restriction, water diuresis or urea) [13, 14, 16] but without
considering the possibility that the way of correction by itself
could contribute to the neuropathological sequelae. In our
previous experiments [15, 21] we have demonstrated that urea,
which efficaciously corrects hyponatremia [5, 32], induced a
lower incidence and severity of brain lesions as compared to
hypertonic saline when the rats were submitted to daily correc-
tion of serum sodium above the threshold of tolerance for the
brain. Interestingly, the results of Verbalis et al [16] can be
interpreted differently considering that brain damage occurred
in animals which had high maximal rates of correction, and that
most of them were treated with i.v. hypertonic saline, when rats
without neuropathological sequelae presented low rates of
correction but were corrected by water restriction alone [16].
The hypervolemia associated with NaCI infusion could have
potential deleterious effect on the brain through hypothetical
mechanisms like the increase in cerebral blood flow, an exces-
sive water loss from the brain enhanced by the atrial natriuretic
factor [33], or a direct ion-induced injury due to the overshoot
of brain Na and Cl levels observed after NaC1 administration
[281.
The rats of group 1 were submitted to an acute and important
osmotic stress (serum sodium rose 12 mEq/liter in 1 hr, range 8
to 17 mEq/liter) with a concomittant volume expansion, as
illustrated by the significant fall in the hematocrit and plasma
protein values. However, no difference could be observed in
the outcome with group 2, where rats were corrected with a
model of volume contraction through water restriction. The
incidence of brain lesion was low in both groups (1 of 25 in
group 1 and 2 of 24 in group 2) where the rats achieved daily
change in serum sodium never exceeding 20 mEq/liter/24 hr.
The neuropathological sequelae of a correction between 10 to
20 mEq/liter/24 hr are represented by 6% of damaged rats when
the present series was pooled with our previous results [15] (6 of
96 rats, with 5 asyniptomatic regaining weight, 4 out of them
presenting only minor brain lesions; and 1 symptomatic ani-
mal). In clinical practice, however, this incidence of neurolog-
ical complication is not negligible, and a more prudent approach
would be to not exceed a serum sodium rise of 15 mEq/liter/day,
an increment which can be made rapidly, if necessary.
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